# Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration

> **NCT01773954** · NA · COMPLETED · sponsor: **MidAtlantic Retina** · enrollment: 40 (actual)

## Conditions studied

- Age-Related Macular Degeneration
- Macular Degeneration

## Interventions

- **DRUG:** Intravitreal Aflibercept Injection

## Key facts

- **NCT ID:** NCT01773954
- **Lead sponsor:** MidAtlantic Retina
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01773954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01773954, "Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01773954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*